Bispecific antibodies in cancer therapy: Target selection and regulatory requirements

In recent years, the development of bispecific antibodies (bsAbs) has been rapid, with many new structures and target combinations being created. The boom in bsAbs has led to the successive issuance of industry guidance for their development in the US and China. However, there is a high degree of si...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanze Sun (Author), Xinmiao Yu (Author), Xiao Wang (Author), Kai Yuan (Author), Gefei Wang (Author), Lingrong Hu (Author), Guoyu Zhang (Author), Wenli Pei (Author), Liping Wang (Author), Chengliang Sun (Author), Peng Yang (Author)
Format: Book
Published: Elsevier, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available